Sanuwave Health EPS - Earnings per Share 2010-2024 | SNWVD
Sanuwave Health eps - earnings per share from 2010 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Sanuwave Health Annual EPS |
| 2023 |
$-0.03 |
| 2022 |
$-0.02 |
| 2021 |
$-0.05 |
| 2020 |
$-0.08 |
| 2019 |
$-0.05 |
| 2018 |
$-0.08 |
| 2017 |
$-0.04 |
| 2016 |
$-0.06 |
| 2015 |
$-0.08 |
| 2014 |
$-0.12 |
| 2013 |
$-0.40 |
| 2012 |
$-0.30 |
| 2011 |
$-0.52 |
| 2010 |
$-1.15 |
| 2009 |
$-0.54 |
| Sanuwave Health Quarterly EPS |
| 2024-06-30 |
$0.01 |
| 2024-03-31 |
$0.00 |
| 2023-12-31 |
$0.03 |
| 2023-09-30 |
$-0.03 |
| 2023-06-30 |
$-0.01 |
| 2023-03-31 |
$-0.02 |
| 2022-12-31 |
$-0.01 |
| 2022-09-30 |
$0.00 |
| 2022-06-30 |
$0.00 |
| 2022-03-31 |
$-0.01 |
| 2021-12-31 |
$-0.01 |
| 2021-09-30 |
$-0.01 |
| 2021-06-30 |
$-0.02 |
| 2021-03-31 |
$-0.01 |
| 2020-12-31 |
$-0.03 |
| 2020-09-30 |
$-0.03 |
| 2020-06-30 |
$-0.01 |
| 2020-03-31 |
$-0.01 |
| 2019-12-31 |
$-0.01 |
| 2019-09-30 |
$-0.01 |
| 2019-06-30 |
$-0.02 |
| 2019-03-31 |
$-0.01 |
| 2018-12-31 |
$-0.01 |
| 2018-09-30 |
$-0.01 |
| 2018-06-30 |
$-0.02 |
| 2018-03-31 |
$-0.04 |
| 2017-12-31 |
$-0.02 |
| 2017-09-30 |
$-0.01 |
| 2017-06-30 |
$-0.01 |
| 2017-03-31 |
$-0.00 |
| 2016-12-31 |
$-0.02 |
| 2016-09-30 |
$-0.01 |
| 2016-06-30 |
$-0.01 |
| 2016-03-31 |
$-0.02 |
| 2015-12-31 |
$-0.02 |
| 2015-09-30 |
$-0.02 |
| 2015-06-30 |
$-0.02 |
| 2015-03-31 |
$-0.02 |
| 2014-12-31 |
$0.00 |
| 2014-09-30 |
$-0.03 |
| 2014-06-30 |
$-0.03 |
| 2014-03-31 |
$-0.06 |
| 2013-12-31 |
$0.03 |
| 2013-09-30 |
$-0.14 |
| 2013-06-30 |
$-0.04 |
| 2013-03-31 |
$-0.25 |
| 2012-12-31 |
$-0.07 |
| 2012-09-30 |
$-0.07 |
| 2012-06-30 |
$-0.07 |
| 2012-03-31 |
$-0.09 |
| 2011-12-31 |
$-0.11 |
| 2011-09-30 |
$-0.10 |
| 2011-06-30 |
$-0.17 |
| 2011-03-31 |
$-0.14 |
| 2010-12-31 |
$-0.48 |
| 2010-09-30 |
$-0.21 |
| 2010-06-30 |
$-0.22 |
| 2010-03-31 |
$-0.24 |
| 2009-12-31 |
$-0.23 |
| 2009-09-30 |
$-0.24 |
| 2009-06-30 |
$0.10 |
| 2009-03-31 |
$-0.17 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$0.056B |
$0.020B |
|
SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA.
|
